As of 2024-12-14, the Relative Valuation of Relay Therapeutics Inc (RLAY) is (97.02) USD. This relative valuation is based on P/E multiples. With the latest stock price at 4.71 USD, the upside of Relay Therapeutics Inc based on Relative Valuation is -2159.8%.
The range of the Relative Valuation is (99.40) - (102.28) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 27.6x - 40.2x | 34.4x |
| Forward P/E multiples | 19.0x - 28.4x | 19.4x |
| Fair Price | (99.40) - (102.28) | (97.02) |
| Upside | -2210.4% - -2271.6% | -2159.8% |
| Date | P/E |
| 2024-12-11 | -1.38 |
| 2024-12-10 | -1.23 |
| 2024-12-09 | -1.30 |
| 2024-12-06 | -1.28 |
| 2024-12-05 | -1.19 |
| 2024-12-04 | -1.22 |
| 2024-12-03 | -1.22 |
| 2024-12-02 | -1.29 |
| 2024-11-29 | -1.30 |
| 2024-11-27 | -1.33 |
| 2024-11-26 | -1.32 |
| 2024-11-25 | -1.35 |
| 2024-11-22 | -1.32 |
| 2024-11-21 | -1.29 |
| 2024-11-20 | -1.29 |
| 2024-11-19 | -1.33 |
| 2024-11-18 | -1.36 |
| 2024-11-15 | -1.42 |
| 2024-11-14 | -1.55 |
| 2024-11-13 | -1.61 |
| 2024-11-12 | -1.65 |
| 2024-11-11 | -1.71 |
| 2024-11-08 | -1.72 |
| 2024-11-07 | -1.70 |
| 2024-11-06 | -1.73 |
| 2024-11-05 | -1.65 |
| 2024-11-04 | -1.62 |
| 2024-11-01 | -1.62 |
| 2024-10-31 | -1.56 |
| 2024-10-30 | -1.58 |
| 2024-10-29 | -1.64 |
| 2024-10-28 | -1.67 |
| 2024-10-25 | -1.67 |
| 2024-10-24 | -1.72 |
| 2024-10-23 | -1.75 |
| 2024-10-22 | -1.85 |
| 2024-10-21 | -1.78 |
| 2024-10-18 | -1.87 |
| 2024-10-17 | -1.84 |
| 2024-10-16 | -1.89 |
| 2024-10-15 | -1.87 |
| 2024-10-14 | -1.87 |
| 2024-10-11 | -1.89 |
| 2024-10-10 | -1.82 |
| 2024-10-09 | -1.78 |
| 2024-10-08 | -1.73 |
| 2024-10-07 | -1.76 |
| 2024-10-04 | -1.81 |
| 2024-10-03 | -1.80 |
| 2024-10-02 | -1.80 |